Local Hospital Held 3rd Annual Spooktacular Stroke Awareness 5K

Translate to Spanish or other 102 languages!

To help bring awareness to this epidemic in America, Rio Grande Regional Hospital hosted its 3rd Annual Spooktacular 5k Run/Walk on October 23rd. Courtesy Image
To help bring awareness to this epidemic in America, Rio Grande Regional Hospital hosted its 3rd Annual Spooktacular 5k Run/Walk on October 23rd. Courtesy Image

Mega Doctor News

- Advertisement -

MCALLEN, Texas – World Stroke Day is observed on October 29 to underscore the serious nature and high rates of stroke.  This day is dedicated to help raise awareness of the prevention and treatment of the condition, to help ensure better care and support for survivors.  Stroke is the number two cause of death in the world and the fifth leading cause of death in the U.S.

To help bring awareness to this epidemic in America, Rio Grande Regional Hospital hosted its 3rd Annual Spooktacular 5k Run/Walk on October 23rd.  Dr. Hamzah Saei, Vascular/Neurologist and Dr. Kevin McMahon, Epileptologist/Neurologist spoke to the crowd and explained the signs and symptoms of a stroke.  In addition, the physicians also encouraged everyone to BE FAST.  BE FAST is an acronym to help detect and enhance responsiveness to the needs of a person having a stroke. The acronym stands for Balance difficulties, Eyesight changes, Facial drooping, Arm weakness, Speech difficulties and Time to call 911. 

PICTURED in RGRH 5K Committee Members:
Front (L-R):  Dr. K. McMahon, Dr. H. Saei
          Middle:  Iza Luna
          Back (L-R):  Adriana Morales, Theresa Escobar, Dulce Olivarez, Claudia Irizarry, David Irizarry, COO
 

Rio Grande Regional Hospital, a Certified Advanced Primary Stroke Center, was recognized by the American Heart Association with the 2021 GWTG Stroke GOLD PLUS with Honor Roll Elite and Target: Type 2 Diabetes Honor Roll. This recognition showcases Rio Grande Regional Hospital’s continuous commitment to provide the residents of the Rio Grande Valley with high quality care while reducing risks and improving lives.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Study: Supplement Plus Chemo Boosts Pancreatic Cancer Survival

L-glutamine, an amino acid that occurs naturally in the body and plays an important role in digestion, has been studied as a potential way to ease side effects in other cancers.

How Artificial Intelligence Is Improving Prostate Cancer Diagnostics

Mega Doctor News CLEVELAND CLINIC - September is Prostate Cancer Awareness Month.  Prostate cancer is...

FDA Approves First Drug of Its Kind for Polycythemia Vera, a Rare Blood Disorder

The U.S. Food and Drug Administration today approved Mimrylo (rusfertide), a new treatment for adults with polycythemia vera, a rare blood disorder that causes the body to make too many red blood cells.

FDA Approves First Oral Drug Indicated to Treat Dermatomyositis in Adults

Lisraya is the first FDA-approved oral treatment option for patients with dermatomyositis, addressing the high unmet need for this rare disease.
- Advertisement -